Contact this trialFirst, we need to learn more about you.
CAR T-cell Therapy
KK-LC-1 TCR Gene Therapy for Cancer
Recruiting1 awardPhase 1
Bethesda, Maryland
This trial is testing a new way to treat cancer by targeting KK-LC-1, a cancer germline antigen, with T cell therapy. Researchers will test the safety of different doses of KK-LC-1 TCR T cells plus aldesleukin to treat metastatic or refractory/recurrent KK-LC-1 positive cancers.
Fill-in a few details and create your profileHaving a profile will help us send you recommended trials and speed up your application in the future.
We will keep your details privateWe won’t share unless you give us permission. By completing this form you agree to our privacy policy
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.